Early menopause tied to greater type 2 diabetes risk

Early menopause tied to greater type 2 diabetes risk
Women who experience early menopause have a greater risk of type 2 diabetes, according to a study published online Dec. 10 in Diabetes Care.

(HealthDay)—Women who experience early menopause have a greater risk of type 2 diabetes, according to a study published online Dec. 10 in Diabetes Care.

Judith S. Brand, from the University Medical Center Utrecht in the Netherlands, and colleagues analyzed data from 3,691 postmenopausal case subjects with type 2 diabetes and 4,408 subcohort members included in the InterAct study, a prospective case-cohort study nested within the European Prospective Investigation into Cancer and Nutrition study.

The researchers found that, over a median follow-up of 11 years, relative to women with menopause at age 50 to 54 years, for women with menopause at ages younger than 40; 40 to 44; 45 to 49; and 55 years and older, the hazard ratios (HRs) for type 2 diabetes were 1.32 (95 percent confidence interval [CI], 1.04 to 1.69); 1.09 (95 percent CI, 0.90 to 1.31); 0.97 (95 percent CI, 0.86 to 1.10); and 0.85 (95 percent CI, 0.70 to 1.03), respectively. There was a higher with shorter reproductive life span (HR per SD lower reproductive life span, 1.06; 95 percent CI, 1.01 to 1.12). The effect was not significantly modified by , , or smoking.

"Early menopause is associated with a greater risk of type 2 diabetes," Brand and colleagues conclude.

One author disclosed receiving funding from .

More information: Abstract
Full Text (subscription or payment may be required)

Journal information: Diabetes Care

Copyright © 2012 HealthDay. All rights reserved.

Citation: Early menopause tied to greater type 2 diabetes risk (2012, December 27) retrieved 27 April 2024 from https://medicalxpress.com/news/2012-12-early-menopause-tied-greater-diabetes.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Clopidogrel after MI less effective in diabetes patients

 shares

Feedback to editors